CVS Health (NYSE: CVS) reported Q1 EPS of $2.25, $0.61 better than the analyst estimate of $1.64. Revenue for the quarter came in at $94.6 billion versus the consensus estimate of $93.07 billion.

GUIDANCE:

CVS Health sees FY2025 EPS of $6.00-$6.20, versus the consensus of $5.91.

For earnings history and earnings-related data on CVS Health (CVS) click here.